Table 1 Characteristics for the 54 patients entered into the study

From: Prolonged repeated vaccine immuno-chemotherapy induces long-term clinical responses and survival for advanced metastatic melanoma

*Parameter*	*VCML treated (n = 54)*
*Age (Yrs)*
Mean	61.6
Median	66
*Range*	35-97
<55	18
55- < 65	14
65+	22
*Gender*
Male	32
Female	22
Performance status
	ECOG	UICC
	0 = 51	0 = 51
	1 = 2	1 = 2
	2 = 1	2 = 1
M classification
IIIb	1 (2%)
IIIc	5 (9%)
M1a	6 (11%)
M1b	14 (26%)
M1c	28 (52%)

Back to article page